Cannabis Use in Adults Who Screen Positive for Attention Deficit/Hyperactivity Disorder: CANreduce 2.0 Randomized Controlled Trial Subgroup Analysis

BACKGROUND: Prevalence rates for lifetime cannabis use and cannabis use disorder are much higher in people with attention deficit/hyperactivity disorder than in those without. CANreduce 2.0 is an intervention that is generally effective at reducing cannabis use in cannabis misusers. This self-guided...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahlers, Joachim, Baumgartner, Christian, Augsburger, Mareike, Wenger, Andreas, Malischnig, Doris, Boumparis, Nikolaos, Berger, Thomas, Stark, Lars, Ebert, David D, Haug, Severin, Schaub, Michael P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069287/
https://www.ncbi.nlm.nih.gov/pubmed/35442196
http://dx.doi.org/10.2196/30138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069287/
https://www.ncbi.nlm.nih.gov/pubmed/35442196
http://dx.doi.org/10.2196/30138

Ejemplares similares